JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE704.7014.25 (+2.06 %)

PREV CLOSE ( ) 690.45

OPEN PRICE ( ) 700.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3748

TODAY'S LOW / HIGH ( )678.20 705.00

52 WK LOW / HIGH ( ) 452.1760

NSE

This Company is not listed in NSE

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985

Management Info

Ashish U Bhuta - Chairman Ashish U Bhuta - Managing Director

Registered Office

Address Nirmala Apartments,93 Jayprakash Road,Andheri (West),
Mumbai,
Maharashtra-400058

Phone 022-67603603

Email investor@jenburkt.com / info@jenburkt.com

Website www.jenburkt.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE

NEWS

14Mar Jenburkt Pharmaceuticals informs about
Jenburkt Pharmaceuticals has informed that it enclosed the details of th..

02Mar Jenburkt Pharmaceuticals informs about
Jenburkt Pharmaceuticals has informed that it submitted the daily report..

08Feb Jenburkt Pharmaceuticals informs about
With reference to its letter No. JPL/CS/1899/2023 dated 7th February, 20..

12Jan Jenburkt Pharmaceuticals submits daily
Pursuant to provisions of Regulation 18(i) of the Buy-back Regulations,..

22Dec Jenburkt Pharmaceuticals informs about
Jenburkt Pharmaceuticals has informed that the exchange has received the..

Financials

in Millions

	QTR Dec 22	ANNUAL 22
Net Profit	54.34	222.96
Gross Profit	77.57	298.7
Operating Profit	84.44	322.04
Net Sales	345.66	1239.8

EVENT CALENDAR

peer group

Gland Pharma (BSE) 1231.75 (5.84%)	M.Cap ( in Cr)20285.72
Natural Capsules (BSE) 432.30 (9.54%)	M.Cap ( in Cr)404.16
AMI Organics (BSE) 934.50 (3.72%)	M.Cap ( in Cr)3405.04
RPG Life Sciences (BSE) 746.60 (4.65%)	M.Cap ( in Cr)1234.80
Ajanta Pharma (BSE) 1206.80 (2.01%)	M.Cap ( in Cr)15462.14

	NON-INSTITUTION	50.54%
	PROMOTERS	45.97%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
No Data Found

About Jenburkt Pharmaceuticals Ltd.

Jenburkt Pharmaceuticals Ltd. was incorporated in the year 1985. Its today's share price is 704.7. Its current market capitalisation stands at Rs 311.51 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1239.8 Cr and Total Income of Rs.1289.29 Cr. The company's management includes Ashish R Shah, Hina R Mehta, Arun R Raskapurwala, Rameshchandra J Vora, Bharat V Bhate, Dilip H Bhuta, Ashish U Bhuta, Ashish U Bhuta.

It is listed on the BSE with a BSE Code of 524731 , NSE with an NSE Symbol of and ISIN of INE354A01013. It's Registered office is at Nirmala Apartments,93 Jayprakash Road,Andheri (West)Mumbai-400058, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are DL Arora & Co, DR Mehta & Associates

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances NPS Grievance Policy SEBI Scores RMS Policy Inspection CSR Committee CSR Policy

CSR Activities

FY-2020-2021 FY-2021-2022 FY-2022-2023

Investor Charter

Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Evoting

NSDL Evoting CDSL Evoting

Client Bank Account list

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote